Izbicki J R, Wambach G, Hamilton S R, Harnisch E, Hogenschurz R, Izbicki W, Kusche J
J Cancer Res Clin Oncol. 1986;112(1):39-46. doi: 10.1007/BF00394937.
Sex hormones may play a role in colonic carcinogenesis, as evidenced by epidemiologic and experimental data showing different tumor rates in males and females. We investigated the effects of hormonal manipulation on tumor development and on androgen receptor binding in both colonic wall and experimentally induced tumors in male rats. Five of six groups, each with 40 animals, were given 10 weekly s.c. injections of azoxymethane (AOM), 7.5 mg/kg body weight. Group-I served as normal controls. Group-II received AOM only. Group-III was castrated 2 weeks prior to carcinogen treatment. Group-IV was castrated similarly and then hormone substituted with testosterone propionate. Group-V was chemically castrated with the anti androgen cyproterone acetate. Group-VI was castrated and given hormone vehicle. Scatchard analysis for androgen receptors in cytosol from normal colonic wall and tumor was performed with 3H-methyltrienolone as the ligand. Androgens were found to have an inhibitory effect on carcinogenesis: chemical castration increased colonic tumor development (P less than 0.05 for multiplicity), and testosterone administration produced a borderline statistically significant reduction in tumor incidence in surgically castrated rats (P less than 0.053), particularly in the right colon. Specific binding sites for androgen with high affinity and low capacity were found in the colonic wall of all groups. Receptor density was not altered by AOM administration, but increased after surgical castration. Receptor density was markedly lower in tumors than in normal colonic wall. Receptor binding sites in tumors were not altered by the various hormonal manipulations. Our study demonstrated that although cytoplasmic androgen receptors are present in colonic wall and in experimental tumors, AOM-induced colonic carcinogenesis appears to be only mildly affected by manipulation of androgens.
性激素可能在结肠癌发生过程中发挥作用,流行病学和实验数据表明男性和女性的肿瘤发生率不同,这证明了这一点。我们研究了激素调节对雄性大鼠结肠壁和实验诱导肿瘤的肿瘤发展以及雄激素受体结合的影响。六组中的五组,每组40只动物,每周皮下注射10次氮杂环丙烷(AOM),剂量为7.5mg/kg体重。第一组作为正常对照。第二组仅接受AOM。第三组在致癌物处理前2周进行去势。第四组同样进行去势,然后用丙酸睾酮进行激素替代。第五组用抗雄激素醋酸环丙孕酮进行化学去势。第六组进行去势并给予激素载体。以3H-甲基三烯olone为配体,对正常结肠壁和肿瘤细胞质中的雄激素受体进行Scatchard分析。发现雄激素对致癌作用有抑制作用:化学去势增加了结肠肿瘤的发展(多灶性P<0.05),而给予睾酮使手术去势大鼠的肿瘤发生率有统计学意义的临界降低(P<0.053),特别是在右结肠。在所有组的结肠壁中都发现了具有高亲和力和低容量的雄激素特异性结合位点。给予AOM后受体密度未改变,但手术去势后增加。肿瘤中的受体密度明显低于正常结肠壁。肿瘤中的受体结合位点未因各种激素调节而改变。我们的研究表明,虽然结肠壁和实验性肿瘤中存在细胞质雄激素受体,但AOM诱导的结肠癌发生似乎仅受到雄激素调节的轻微影响。